Sanofi SA
Sanofi
Pricing is indicative. Past performance is not a reliable indicator of future results. Client sentiment is provided for general information only, is historical in nature and is not intended to provide any form of trading or investment advice - it must not form the basis of your trading or investment decisions.
Trading Conditions
ATP Margin
0.04
Contract Size Currency per 1 Lot Symbol
1 Share
Min/Max Trade Size (lots)
1 Share / 25000
Schedule and Fees
Market Open
Monday 09:00 CET
Market Closed
Friday 17:30 CET
Trading Break
17:30 - 09:00 CET
3 Day Financing
Wednesday
Long & Short Position Overnight Fee
displayed on the trading platform
FAQ
Sanofi is a global pharmaceutical company renowned for its extensive operations in the research, development, manufacturing, and distribution of a wide range of pharmaceutical products and healthcare solutions. The company dates back to 1973, and it has since grown into one of the largest and most influential players in the pharmaceutical industry. Sanofi’s operations encompass multiple therapeutic areas, including vaccines, rare diseases, diabetes, oncology, cardiovascular diseases, and more.
Sanofi invests heavily in research and development with the aim of creating new drugs and therapies that address critical medical needs. The company operates research centres around the world, collaborating with academic institutions and other partners to drive scientific advancement. Additionally, Sanofi boasts a global manufacturing network that ensures consistent global production and distribution of pharmaceuticals to patients.
Sanofi is listed on several stock exchanges around the world. One of the primary stock exchanges where Sanofi is listed is Euronext Paris, the main stock exchange in France, where it trades with the ticker symbol “SAN”. Sanofi is also a component of the French stock market index CAC 40, which represents the 40 largest publicly traded companies in France.
